Core Viewpoint - The company has decided not to adjust the conversion price of the "Shou 22 Convertible Bonds" despite triggering conditions for a downward adjustment, citing confidence in its future development potential and the need to treat all investors fairly [1][6]. Group 1: Convertible Bond Issuance and Terms - The company issued 3.98 million convertible bonds on November 17, 2022, with a total amount of 398 million yuan, and the bonds are set to mature on November 16, 2028 [2]. - The initial conversion price was set at 38.08 yuan per share, which has been adjusted to 36.84 yuan per share as of the latest update [2][4]. - The conversion period for the bonds is from May 23, 2023, to November 16, 2028 [1]. Group 2: Conversion Price Adjustment Conditions - The conversion price can be adjusted downward if the company's stock price is below 85% of the current conversion price for at least 15 out of 30 consecutive trading days [5]. - The specific threshold for triggering the adjustment was set at 31.31 yuan per share [4][5]. Group 3: Board Decision on Price Adjustment - On September 15, 2025, the board unanimously decided not to adjust the conversion price, with all five votes in favor and no opposition [5]. - The board will reassess the situation if the adjustment conditions are triggered again within the next six months, starting from September 16, 2025 [6].
浙江寿仙谷医药股份有限公司 关于不向下修正“寿22转债”转股价格的公告